Healthy Extracts (HYEX) Cost of Revenue (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Cost of Revenue came in at $736658.0 in Q4 2025, up 106.48% year-on-year from $356774.0 in Q4 2024, and up 56.49% quarter-over-quarter from $470725.0 in Q3 2025.
Healthy Extracts (HYEX) Cost of Revenue (2015 - 2025) Analysis & Trends
Healthy Extracts' Cost of Revenue history runs 11 years deep, the most recent figure standing at $736658.0 for Q4 2025.
- On a quarterly basis, Cost of Revenue rose 106.48% year-over-year to $736658.0 in Q4 2025; TTM through Dec 2025 was $2.1 million, a 73.84% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 73.84% from the prior year.
- Cost of Revenue rose to $736658.0 in Q4 2025 per HYEX's latest filing, from $470725.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $736658.0 in Q4 2025 and bottomed at $33764.0 in Q2 2021.
- The 5-year median for Cost of Revenue is $291921.5 (2023), against an average of $298482.5.
- Across the five-year window, Cost of Revenue soared 4056.03% in 2021 and sank 78.37% in 2023, its largest moves.
- Year by year, Cost of Revenue stood at $623248.0 in 2021, then slipped by 23.44% to $477163.0 in 2022, then sank by 78.37% to $103230.0 in 2023, then surged by 245.61% to $356774.0 in 2024, then surged by 106.48% to $736658.0 in 2025.
- Per Business Quant, the three latest HYEX Cost of Revenue figures stand at $736658.0 (Q4 2025), $470725.0 (Q3 2025), and $375828.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 736,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 736,658.00 |
| Dec 31, 2025 | 736,658.00 |
| Sep 30, 2025 | 470,725.00 |
| Sep 30, 2025 | 470,725.00 |
| Jun 30, 2025 | 375,828.00 |
| Jun 30, 2025 | 375,828.00 |
| Mar 31, 2025 | 506,295.00 |
| Mar 31, 2025 | 506,295.00 |
| Dec 31, 2024 | 356,774.00 |
| Dec 31, 2024 | 356,774.00 |
| Sep 30, 2024 | 142,456.00 |
| Sep 30, 2024 | 142,456.00 |
| Jun 30, 2024 | 422,301.00 |
| Jun 30, 2024 | 422,301.00 |
| Mar 31, 2024 | 280,428.00 |
| Mar 31, 2024 | 280,428.00 |
| Dec 31, 2023 | 103,230.00 |
| Dec 31, 2023 | 103,230.00 |
| Sep 30, 2023 | 120,309.00 |
| Sep 30, 2023 | 120,309.00 |